Breaking News Instant updates and real-time market news.

TWTR

Twitter

$32.66

0.55 (1.71%)

, AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

10:47
02/24/18
02/24
10:47
02/24/18
10:47

Week in review: How Trump's policies moved stocks

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. FLORIDA SHOOTING: Twitter (TWTR) accounts suspected of having links to Russia released hundreds of posts regarding the gun control debate just one hour after news broke about the mass shooting at Marjory Stoneman Douglas High School in Parkland, Florida, according to a report by The New York Times on Tuesday. The accounts, which used hashtags including #guncontrolnow, #gunreformnow and #Parklandshooting, had previously focused on the investigation by special counsel Robert Meuller into Russian meddling in the 2016 presidential election. The same day, President Donald Trump recommended that bump stocks be banned, according to CNBC. Trump signed a memorandum recommending that Attorney General Jeff Sessions propose regulations that would declare that bump stocks, devices that let semi-automatic weapons fire hundreds of rounds per minute, are illegal because they effectively turn legal semi-automatic weapons into outlawed machine guns, the report added. Publicly traded gun manufacturers include Smith & Wesson parent American Outdoor Brands Corporation (AOBC) and Sturm Ruger & Company (RGR). 2. U.S. STEEL: Last week, the Department of Commerce recommended imposing heavy tariffs or quotas on foreign producers of steel and aluminum in the interest of national security as defined by section 232, following a trade investigation on imports. President Donald Trump will have to respond by April 11 for steel and April 19 for aluminum. Commenting on the news earlier this week, Morgan Stanley analyst Piyush Sood told investors that he sees a tariff plus quota scenario as the most likely and U.S. Steel (X) as a key beneficiary from higher prices and demand from the energy sector. All flat rolled producers - including Steel Dynamics (STLD), Nucor (NUE), and AK Steel (AKS) - would benefit from the ensuing tightness, but U.S. Steel would be the biggest beneficiary of higher pricing, he contended. Not as bullish, a peer at the European arm of Credit Suisse cautioned that the situation is more complex than it initially seems. Credit Suisse analyst Michael Shillaker told investors that there is likely to be retaliatory action from other nations, export markets could become log-jammed with steel and the outcome may not in fact be as desired in the mid-term. 3. HEALTH INSURANCE: On Wednesday, The New York Times reported that the Trump administration has proposed new rules that would make it easier for consumers to purchase less expensive health insurance policies that do not comply with coverage requirements of the Affordable Care Act. The proposal looks to extend the time limit for "short-term, limited duration insurance" to 364 days which currently cannot last over three months under current rules. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.

TWTR

Twitter

$32.66

0.55 (1.71%)

AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

RGR

Sturm, Ruger

$49.90

0.9 (1.84%)

X

U.S. Steel

$43.52

0.54 (1.26%)

STLD

Steel Dynamics

$47.47

-0.53 (-1.10%)

NUE

Nucor

$66.94

-0.01 (-0.01%)

AKS

AK Steel

$5.50

-0.12 (-2.14%)

AET

Aetna

$175.55

0.49 (0.28%)

ANTM

Anthem

$235.24

1.56 (0.67%)

CNC

Centene

$100.45

0.96 (0.96%)

CI

Cigna

$194.79

2.89 (1.51%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$271.19

3.38 (1.26%)

MOH

Molina Healthcare

$72.94

1.38 (1.93%)

UNH

UnitedHealth

$230.16

3.07 (1.35%)

WCG

WellCare

$192.05

0.03 (0.02%)

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 07

    Mar

  • 13

    Mar

  • 16

    Apr

  • 30

    May

TWTR Twitter
$32.66

0.55 (1.71%)

02/12/18
BMOC
02/12/18
NO CHANGE
Target $28
BMOC
Market Perform
Twitter price target raised to $28 from $22 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Twitter (TWTR) to $28 after Q1 results, saying the company has a "clearer strategy" to sustain its revenue momentum thanks to video and AI helping grow mainstream adoption. As top-line pressures fade, writes the analyst in his research note titled "Solid Steps Down Road to Recovery", the stock could become "more interesting", though he is also weary of Facebook (FB) competition still "looming large". Salmon keeps a Market Perform rating on Twitter.
02/15/18
MSCO
02/15/18
NO CHANGE
Target $28
MSCO
Underweight
Twitter price target raised to $28 from $15 at Morgan Stanley
Morgan Stanley analyst Brian Nowak said he underestimated Twitter's (TWTR) turnaround efforts throughout 2017 and he has raised his price target on the stock to $28 from $15 given the company's better revenue outlook and high incremental margins. However, despite Twitter's better than expected results, he still sees the stock being a relative underperformer from current levels when compared to faster growing peers like Facebook (FB) and Alphabet (GOOGL), he tells investors. Nowak keeps an Underweight rating on Twitter.
02/09/18
02/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Sector Perform from Underperform at RBC Capital with analyst Mark Mahaney saying the fourth quarter revenue and EBITDA were materially better than expected, and while MAU's were below consensus, DAU's grew for the first time at a double-digit rate. 2. iRobot (IRBT) upgraded to Outperform from Market Perform at Raymond James with analyst Mark Strouse saying he sees a more balanced risk/reward following the recent pullback in the shares. 3. Regeneron (REGN) upgraded to Outperform from Neutral at Baird with analyst Brian Skorney noting its selloff since last year and believes its valuation has reached a point where the selloff is overdone. 4. Teva (TEVA) upgraded to Sector Perform from Underperform at RBC Capital with analyst Randall Stanicky saying the 11% sell-off in the stock price following the company's guidance update has removed the debate around 2018 EBITDA target and sees limited downside from the current levels. 5. United Technologies (UTX) upgraded to Buy from Hold at Argus with analyst John Eade saying the company remains a leader in a number of global industries and should continue to benefit from population growth and middle class expansion in developing markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/18
RHCO
02/09/18
NO CHANGE
Target $29
RHCO
Hold
Twitter price target raised to $29 from $18 at SunTrust
SunTrust analyst Youssef Squali raised his price target on Twitter to $29 after improved monetization seen in the company's Q4 earnings, but says the flat MAU's and high valuation keeps his rating on Hold. Squali points to "growing user engagement and better cost containment leading to record high margins and free cash flow" and believes the momentum is likely sustainable as Twitter management improves the product and the ad platform to attract larger advertisers.
AOBC American Outdoor Brands
$10.00

-0.12 (-1.19%)

12/08/17
CHLM
12/08/17
NO CHANGE
Target $15
CHLM
Hold
American Outdoor Brands price target lowered to $15 from $17 at Craig-Hallum
Craig-Hallum analyst Steven Dyer noted that American Outdoor Brands cut its second half outlook due to the continuation of higher promotional levels and said it remains to be seen is if normal buying will pick up when promotions lessen. He lowered his estimates after the company's guidance cut and lowered his price target on the shares to $15 from $17 while keeping a Hold rating on American Outdoor.
12/08/17
IFSG
12/08/17
UPGRADE
IFSG
Strong Buy
American Outdoor Brands upgraded to Strong Buy from Outperform at IFS Securities
12/08/17
WEDB
12/08/17
NO CHANGE
Target $19.5
WEDB
Outperform
American Outdoor guidance reset an 'important' first step, says Wedbush
Noting that the Street has had a low degree of confidence in the consensus projections for American Outdoor Brands for some time, Wedbush analyst James Hardiman said the company took "a first and important step" with its significant reduction of its FY18 earnings guidance. While the Street probably still won't believe the updated estimates until there is some evidence of bottoming, Hardiman said he still views the stock as significantly undervalued compared to his lowered estimates and he maintains an Outperform rating and $19.50 price target on American Outdoor shares, which are down 16% in pre-market trading to $12.49.
12/08/17
12/08/17
UPGRADE

Strong Buy
American Outdoor Brands upgraded to Strong Buy on valuation at IFS Securities
As previously reported, IFS Securities upgraded American Outdoor Brands to Strong Buy from Outperform with a $18 price target. Analyst Ronald Bookbinder believes all the bad news from the Q3 report and FY18 guidance is reflected in valuation and continues to expect NICS will turn positive n December, inventory will be reduced, and the company will take market share as it launches new products at compelling price points.
RGR Sturm, Ruger
$49.90

0.9 (1.84%)

03/14/17
WDLK
03/14/17
INITIATION
Target $51
WDLK
Hold
Sturm, Ruger initiated with a Hold at Wunderlich
Wunderlich analyst Rommel Dionsio started Sturm, Ruger with a Hold rating and $51 price target.
03/14/17
03/14/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Herbalife (HLF) initiated with a Neutral at Citi. 2. OPKO Health (OPK) initiated with a Buy at Guggenheim. 3. Bojangles (BOJA) initiated with an Outperform at Cowen. 4. Sturm, Ruger (RGR) initiated with a Hold at Wunderlich. 5. Wayfair (W) initiated with an Overweight at Stephens. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/21/17
08/21/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on the today's top five analyst initiations with this list compiled by The Fly: 1. Sienna Biopharmaceuticals (SNNA) initiated with an Outperform at BMO Capital, an Overweight at JPMorgan and an Outperform at Cowen. 2. Maxim analyst James Jang initiated coverage of the dry bulk shipping sector, starting Seanergy Marine (SHIP), Safe Bulkers (SB), Euroseas (ESEA) and Eagle Bulk Shipping (EGLE) with Buy ratings. 3. Buckingham analyst Matthew Brooklier started coverage of Knight Transportation (KNX), Werner (WERN) and Ryder (R) with Buy ratings and Old Dominion (ODFL) with a Neutral rating. 4. Baker Hughes (BHGE) initiated with a Buy at Argus. 5. Sturm, Ruger (RGR) initiated with a Buy at Aegis. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/21/17
AGIS
08/21/17
INITIATION
Target $67
AGIS
Buy
Sturm, Ruger initiated with a Buy at Aegis
Aegis analyst Rommel Dionisio started Sturm, Ruger with a Buy rating and $67 price target, stating that his channel checks of U.S. firearms dealers and distributors show they expect inventory destocking to end within the next two to three months.
X U.S. Steel
$43.52

0.54 (1.26%)

02/02/18
BMOC
02/02/18
NO CHANGE
Target $40
BMOC
Market Perform
U.S. Steel price target raised to $40 from $33 at BMO Capital
BMO Capital analyst David Gagliano raised his price target on U.S. Steel to $40 after Q4 earnings, citing expectations of higher underlying prices. The analyst notes however that shares are near their fair value, keeping his Market Perform rating, also adding that there is limited potential for incremental EBITDA upside this year.
02/20/18
MSCO
02/20/18
NO CHANGE
MSCO
U.S. Steel a key beneficiary of Section 232 scenarios, says Morgan Stanley
After the Department of Commerce released its report on U.S. investigations into the impact on national security from imports of steel mill products, Morgan Stanley analyst Piyush Sood explored the three steel import scenarios presented, saying he assign the highest probability to the "tariff+quota" scenario. In all scenarios, he sees outsized gains for pipe/tube/OCTG producers and a tighter flat rolled market, calling U.S. Steel (X) a "key beneficiary." He thinks other flat rolled producers - including Steel Dynamics (STLD), Nucor (NUE) and AK Steel (AKS) - would benefit from greater tightness, but sees U.S. Steel as the biggest beneficiary of higher pricing, he tells investors.
01/30/18
01/30/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altair (ALTR) initiated with a Buy at Berenberg. 2. Chemours (CC), Tronox (TROX) and Venator Materials (VNTR) initiated with an Equal Weight at Morgan Stanley. 3. Oclaro (OCLR), Lumentum (LITE) and Acacia Communications (ACIA) initiated with a Buy at Loop Capital. 4. Rocket Pharmaceuticals (RCKT) initiated with an Outperform at Evercore ISI. 5. U.S. Steel (X) initiated with a Sell at Vertical Group. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/21/18
ARGS
02/21/18
NO CHANGE
Target $52
ARGS
Buy
U.S. Steel price target raised to $52 from $41 at Argus
Argus analyst David Coleman raised his price target on U.S. Steel to $52 and kept his Buy rating, citing a Q4 earnings beat as well as the latest measures by the U.S. Commerce Department to place new tariffs and quotas on imported steel and aluminum. Longer term, Coleman keeps his Buy rating on the company based on its asset revitalization plan, which should improve operating efficiency and help to drive growth beyond the 2017 benefits of stronger pricing and continued cost reduction trends.
STLD Steel Dynamics
$47.47

-0.53 (-1.10%)

02/05/18
COWN
02/05/18
NO CHANGE
Target $60
COWN
Outperform
Steel Dynamics outlook remains bright, says Cowen
Cowen analyst Novid Rassouli met with Steel Dynamics management and is now more confident in the company's outlook. He believes the company is well positioned from the standpoint of both industry dynamics and the potential for an opportunistic acquisition during the year. Rassouli reiterated his Outperform rating and $60 price target on Steel Dynamics shares.
01/24/18
COWN
01/24/18
NO CHANGE
Target $60
COWN
Outperform
Steel Dynamics balance sheet optionality underappreciated, says Cowen
Cowen analyst Novid Rassouli noted Steel Dynamics reported strong Q2 results and he expects margins to expand on stable scrap and rising steel prices. He views the company as a compelling investment given the balance sheet optionality, strong free cash flow generation, and consensus estimates that will need to move higher. Rassouli reiterated his Outperform rating and raised his price target to $60 from $53 on Steel Dynamics shares.
01/24/18
FBCO
01/24/18
NO CHANGE
Target $53
FBCO
Outperform
Steel Dynamics price target raised to $53 from $43 at Credit Suisse
Credit Suisse analyst Curt Woodworth raised his price target for Steel Dynamics to $53 from $43 on valuation and to reflect lower tax rate and higher metal spreads. The analyst reiterates an Outperform rating on the shares.
NUE Nucor
$66.94

-0.01 (-0.01%)

01/31/18
FBCO
01/31/18
NO CHANGE
Target $73
FBCO
Outperform
Nucor price target raised to $73 form $67 at Credit Suisse
Credit Suisse analyst Curt Woodworth raised his price target for Nucor to $73 from $67 saying he views the company's earnings release as positive since it slightly exceeded Nucor's preannounced guidance and set a positive tone moving forward, despite some seasonal softness. The analyst reiterates an Outperform rating on the shares.
01/31/18
BMOC
01/31/18
NO CHANGE
Target $72
BMOC
Market Perform
Nucor price target raised to $72 from $62 at BMO Capital
BMO Capital analyst David Gagliano raised his price target on Nucor to $72 after the company's Q4 earnings showed "higher realized price and margin assumptions for FY18/19" amid the ongoing improvements in fundamentals. The analyst keeps his Market Perform rating, adding that despite the expected benefits from pricing and free cash flow trends, the valuation is approaching the "higher end of fair value range".
01/22/18
SBSH
01/22/18
UPGRADE
Target $43
SBSH
Neutral
U.S. Steel upgraded to Neutral from Sell at Citi
Citi analyst Alexander Hacking upgraded U.S. Steel to Neutral and raised his price target for the shares to $43 from $22. The analyst sees steel prices better supported near-term and increased his EBITDA estimates. Expectations for longer term "normalized" earnings should improve to justify current valuation levels, Hacking tells investors in a research note on the Steel sector. His top picks remain Steel Dynamics (STLD), Nucor (NUE) and Commercial Metals (CMC). The analyst raised his price targets for those stocks to $54 from $42, $79 from $66 and $29 from $21, respectively.
AKS AK Steel
$5.50

-0.12 (-2.14%)

01/31/18
01/31/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Market Perform from Outperform at BMO Capital with analyst Tim Long saying that while the press has recently speculated about the order cuts for iPhone X, which he says reflects his first quarter model for a "weaker mix," he is "more concerned by a secular change" for the iPhone product. AK Steel (AKS) downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners saying AK Steel's "disappointing" first quarter and normalized earnings guidance is due to management's "commodity neutral approach," which limits benefits from higher steel prices. 3. U.S. Bancorp (USB) downgraded to Underweight from Neutral at JPMorgan with analyst Vivek Juneja saying the benefit from tax cuts and improving consumer spending are likely to be offset by increased tech spending. 4. Wayfair (W) downgraded to Accumulate from Buy at Gordon Haskett analyst Chuck Grom saying he believes it is important to remain disciplined with the stock at an all-time high, though Grom notes the rating change should not be interpreted as a concern for near-term sales trends, which he believes appear strong. 5. MetLife (MET) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Alex Scott citing ongoing uncertainty from an expanded reserve review following the announcement it will incur a $525M-$575M charge. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/31/18
BOFA
01/31/18
DOWNGRADE
BOFA
Underperform
AK Steel downgraded to Underperform from Buy at BofA/Merrill
01/31/18
01/31/18
DOWNGRADE
Target $5.5

Underperform
AK Steel downgraded to Underperform limited steel leverage at BofA/Merrill
As previously reported, BofA/Merrill downgraded AK Steel to Underperform from Buy and cut its price target to $5.50 from $8. Analyst Timna Tanners said AK Steel's "disappointing" Q1 and normalized earnings guidance is due to management's "commodity neutral approach," which limits benefits from higher steel prices. Tanners said higher costs will likely limit margin expansion and is more cautious on on AK Steel's key automotive end market and free cash flow outlook given high debt levels.
AET Aetna
$175.55

0.49 (0.28%)

02/01/18
02/01/18
DOWNGRADE
Target $69

Underperform
Express Scripts downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Lance Wilkes downgraded Express Scripts to Underperform from Market Perform, with a $69 price target, as he believes tax reform is fully price in and his original concerns on the standalone PBM model remain. Further, the analyst sees additional risks from a potential CVS (CVS)/Aetna (AET) merger and Amazon (AMZN) threats.
01/31/18
RBCM
01/31/18
UPGRADE
Target $98
RBCM
Outperform
Express Scripts upgraded to Outperform at RBC Capital
As reported earlier, RBC Capital analyst George Hill upgraded Express Scripts (ESRX) to Outperform and raised his price target to $98 from $68. Hill cites the "recent sharp pullback on Amazon's (AMZN) healthcare entry" de-risking the stock, while also pointing to the trend of vertical integration as seen in the CVS (CVS)-Aetna (AET) deal. The analyst believes Express Scripts could also become an attractive M&A target as "one of the few remaining assets at scale".
01/31/18
PIPR
01/31/18
NO CHANGE
Target $212
PIPR
Overweight
Piper sees buying opportunity in Aetna after yesterday's pullback
Piper Jaffray analyst Sarah James sees a buying opportunity in Aetna (AET) following yesterday's 3% pullback on the Amazon (AMZN), Berkshire (BRK.A) and JPMorgan (JPM) news. The company yesterday morning posted a solid earnings beat driven by strong cost trend management in the government and commercial businesses, James tells investors in a research note. She raised her price target for Aetna shares to $212 from $207 and keeps an Overweight rating on the name. CVS Health's (CVS) takeout offer now values the shares at $212, up from $207 previously, based on 0.8378 shares of CVS stock plus $145 per share in cash, James points out. The analyst sees a "win-win" setup for the stock based on the deal going through or the company remaining standalone.
01/31/18
FBCO
01/31/18
NO CHANGE
Target $208
FBCO
Neutral
Aetna price target raised to $208 from $200 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Aetna to $208 from $200, citing on track operationally. However, the analyst is cautious on sustainability of tax benefit. He reiterates a Neutral rating on the shares.
ANTM Anthem
$235.24

1.56 (0.67%)

01/31/18
LEER
01/31/18
NO CHANGE
LEER
UnitedHealth, other MCOs should be bought on weakness, says Leerink
Leerink analyst Ana Gupte views MCOs, especially UnitedHealth (UNH), but also Anthem (ANTM), Cigna (CI) and Humana (HUM), as a "solid" buying opportunity on weakness, while remaining cautious on the Drug Value Chain post the sell-off on the Amazon.com (AMZN)/JPMorgan (JPM)/Berkshire Hathaway (BRK.A; BRK.B) announcement. The analyst believes the drug supply chain is ripe for disruption, and Amazon's strengths play to such disruption to improve both cost, transparency and employee satisfaction, though timing as acknowledged by this new alliance is likely medium to long term. President Trump's State of the Union address also focused on drug pricing and affordability along with accelerated generic drug approvals as the top priority, making it more likely that this will be the key focus of the new partnership, she contends.
01/30/18
MSCO
01/30/18
NO CHANGE
MSCO
Amazon healthcare transparency focus negative for Castlight, says Morgan Stanley
Morgan Stanley analysts lead by Ricky Goldwasser, Brian Nowak and Betsy Graseck said Amazon (AMZN), Berkshire (BRK.A) and JPMorgan's (JPM) new healthcare venture is the first evidence of Amazon's potential attempt to disrupt the insurance sector, though they expect this to be a slow process and do not expect material disruption overnight. Noting managed care organizations are tracking toward $15B-$20B in lost market cap, the team calls their move overdone. For this venture to be a direct competitor would require a sales organization, broker relationships and bolt on services, all of which could take time to develop, they stated, calling the pullback in the group "a buying opportunity when headlines slow down." However, Amazon's entry into healthcare transparency is viewed as an incremental negative for Castlight Health (CSLT), on which the firm keeps an Underweight rating. Publicly traded healthcare insurers sliding today include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
01/25/18
BERN
01/25/18
NO CHANGE
Target $312
BERN
Outperform
Anthem named top pick by PBM turnaround at Bernstein
Bernstein analyst Lance Wilkes says Anthem is his top pick for 2018, citing PBM earnings upside, corporate tax reform, commercial self-insurance margins upside and strong government growth, and new leadership/strategic optionality. The analyst reiterates an Outperform rating and $312 price target on the shares.
02/01/18
FBCO
02/01/18
NO CHANGE
Target $280
FBCO
Outperform
Anthem price target raised to $280 from $255 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Anthem to $280 from $255 on "strong" operating momentum with numerous developing opportunities. The analyst reiterates an Outperform rating on the shares.
CNC Centene
$100.45

0.96 (0.96%)

02/21/18
PIPR
02/21/18
NO CHANGE
PIPR
Piper sees 'ideal time' to buy Medicaid Managed Care Organizations
Now is an "ideal time" to step in and buy Medicaid Managed Care Organizations Centene (CNC), Molina Healthcare (MOH) and WellCare (WCG), Piper Jaffray analyst Sarah James tells investors in a research note. The stocks are down 12% over the last few weeks due to a combination of the flu and various reform/waiver concerns, the analyst points out. She does not view these as material and says "this is when you double down." Centene is James' top pick.
02/07/18
OPCO
02/07/18
NO CHANGE
Target $130
OPCO
Outperform
Centene price target raised to $130 from $122 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Centene to $130 from $122, citing Q4 Beat and raised 2018 outlook on exchanges and Tax-Reform. The analyst reiterates an Outperform rating on the shares.
02/07/18
CANT
02/07/18
NO CHANGE
Target $125
CANT
Overweight
Centene price target raised to $125 from $115 at Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper raised his price target for Centene to $115 citing the company's "solid" Q4 results and increased 2018 guidance. In addition to a lower corporate tax rate, Centene indicated that individual exchange enrollment was stronger than expected, Halper tells investors in a research note. The analyst keeps an Overweight rating on the shares.
02/13/18
LEER
02/13/18
NO CHANGE
Target $100
LEER
Market Perform
Centene price target raised to $100 from $90 at Leerink
Leerink analyst Ana Gupte raised her price target for Centene to $100 form $90 saying the Q4 report was "good" and 2018 guidance raise for tax tailwinds was above expectations. The analyst reiterates a Market Perform rating on the shares.
CI Cigna
$194.79

2.89 (1.51%)

02/02/18
OPCO
02/02/18
NO CHANGE
Target $237
OPCO
Outperform
Cigna price target raised to $237 from $220 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Cigna to $237 saying the company's outlook is fiscal 2018 is strong while benefits from tax reform are sustainable. The analyst continues to be a buyer of the stock with an Outperform rating.
02/02/18
LEER
02/02/18
NO CHANGE
Target $250
LEER
Outperform
Cigna recent selloff a buying opportunity, says Leerink
Leerink analyst Ana Gupte views the recent pullback in Cigna shares as a buying opportunity following the company's "solid" Q4 results. News of the Amazon, JPMorgan, Berkshire healthcare coalition, while an overhang, is more headline risk than anything else, Gupte tells investors in a research note. She believes Cigna is likely to build on its "industry-leading" medical cost trend for employers, with a focus on improving the out-of-pocket cost, experience and transparency for the U.S. worker. The analyst reiterates an Outperform rating on the shares with a $250 price target.
HNT Health Net
$0.00

(0.00%)

06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
10/02/17
BERN
10/02/17
NO CHANGE
BERN
Bernstein does not anticipate ACA fix/repeal before 2018 election
While noting the resignation of Health Secretary Tom Price, Bernstein analyst Lance Wilkes says he does not anticipate an Affordable Care act fix or ACA repeal before the 2018 election. The analyst expects tax reform will "suck the oxygen out of the room" until close to the election. A fix for 2019 is possible, but faces the headwind of the 2018 election campaign, he contends, adding that he believes CSR funding could be included in a trade for the upcoming budget and the Health Insurance Fee could be suspended as part of tax reform, but both are not highly likely at this point. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
HUM Humana
$271.19

3.38 (1.26%)

02/08/18
FBCO
02/08/18
UPGRADE
FBCO
Outperform
Humana upgraded to Outperform from Neutral at Credit Suisse
02/08/18
FBCO
02/08/18
UPGRADE
Target $306
FBCO
Outperform
Credit Suisse upgrades Humana ahead of 2019 enrollment growth
Credit Suisse analyst A.J. Rice upgraded Humana to Outperform and raised his price target for the shares to $306 from $259. After ceding market share for "several years," Humana should return to above market individual Medicare Advantage enrollment growth in 2019 as it benefits from a favorable rate update and tax reform, Rice tells investors in a research note. He sees "several drivers" that support his core operating earnings growth assumption of 12% in 2018.
02/08/18
OPCO
02/08/18
NO CHANGE
Target $305
OPCO
Outperform
Humana price target raised to $305 from $275 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Humana to $305 from $275 after the company reported quarterly results. The analyst reiterates an Outperform rating on the shares.
02/08/18
02/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wynn Resorts (WYNN) upgraded to Positive from Neutral at Susquehanna with analyst Rachael Rothman saying the resignation of Steve Wynn removes an overhang. 2. Molson Coors (TAP) upgraded to Hold from Sell at Berenberg with analyst Javier Gonzalez Lastra saying he sees limited downside from the current share price and thinks greater cost savings could be a near-term upside catalyst. 3. Humana (HUM) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying after ceding market share for "several years," Humana should return to above market individual Medicare Advantage enrollment growth in 2019 as it benefits from a favorable rate update and tax reform. 4. Anadarko (APC) upgraded to Outperform from Neutral at Macquarie with analyst Paul Grigel saying he sees sustainable upside into 2018 due to continued strong growth in US production, infrastructure and its advantage in the DJ Basin. 5. Just Energy (JE) was upgraded to Outperformer from Neutral at CIBC and to Buy from Hold at Canaccord. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MOH Molina Healthcare
$72.94

1.38 (1.93%)

02/06/18
PIPR
02/06/18
NO CHANGE
Target $81
PIPR
Overweight
Molina should be bought on weakness from Florida news, says Piper Jaffray
Piper Jaffray analyst Sarah James notes Molina Healthcare this morning announced that it was invited to negotiate for Region 11, but not the remainder of the other seven counties that the company services. Currently, Molina services about 350,000 members in Florida, which the analyst estimate adds $1.06B-$1.48B in revenue and 19c-52c of earnings per share, including 59,000 in region 11. The analyst is surprised with this morning's news, but believes Molina will fight to have this decision overturned. James continues to believe in the company's turnaround story and would be buyers on any weakness today. The analyst has an Overweight rating on the stock. Molina in early trading is down 9% to $79.50.
02/14/18
BMOC
02/14/18
NO CHANGE
Target $85
BMOC
Market Perform
Molina Healthcare price target lowered to $85 from $98 at BMO Capital
BMO Capital analyst Matt Borsch lowered his price target on Molina Healthcare to $85, citing recent losses in Medicaid contracts in New Mexico and Florida on losses in ACA Exchanges. Borsch keeps his Market Perform rating, noting that there have been some signs of improvement in earnings from the company's "core" Medicaid business.
UNH UnitedHealth
$230.16

3.07 (1.35%)

01/24/18
LEER
01/24/18
NO CHANGE
LEER
UnitedHealth well positioned to win partnership with Amazon, says Leerink
Following a MEDACorp Pulse Call with a former member of Amazon CEO Jeff Bezos' senior executive team, Leerink analyst Ana Gupte says she sees UnitedHealth (UNH) Optum Rx as well positioned to win in partnership with Amazon (AMZN) likely through nonexclusive contracts, though the latter is speculated to be joining the Health Transformation Alliance of large employers, of which Optum is part. Consistent with the view that Amazon is unlikely to make large acquisitions, it is expected to repurpose existing warehouses for regulated pharmaceuticals and lab supplies, she contends.
01/30/18
LEER
01/30/18
NO CHANGE
LEER
Unclear if Amazon partnership will accelerate pharmacy supply chain entry, says Leerink
Leerink analyst Ana Gupte notes that Amazon (AMZN), Berkshire Hathaway (BRK.A, BRK.B) and JPMorgan Chase (JPM) have announced that they are forming an independent company that will be free of profit-taking motives and other constraints to improve healthcare costs and satisfaction for employees. The initial focus of the company is stated to be on technology solutions that will provide U.S. employees and their families with simplified high quality and transparent healthcare at a reasonable cost, she adds. The analyst points out that it is unclear if this means Amazon will accelerate its entry into the pharmacy supply chain. Gupte adds that this effort will be separate from the Health Transformation Alliance, which is also a consortium of 46 large self-insured employers looking to transform the healthcare system and includes UnitedHealth (UNH) Optum and CVS (CVS) as suppliers.
WCG WellCare
$192.05

0.03 (0.02%)

01/16/18
JPMS
01/16/18
UPGRADE
Target $103
JPMS
Overweight
Molina Healthcare upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Gary Taylor upgraded Molina Healthcare (MOH) to Overweight and raised his price target for the shares to $103 from $65. New CEO Joe Zubretsky made debut at last week's conference by outlining a faster than expected turnaround, Taylor tells investors in a research note. The analyst sees "no permanent structural reason" why Molina can't ultimately achieve sustainable pretax margins just below peers Centene (CNC) and WellCare (WCG). He raised his estimates for Molina well above consensus and views tax reform as a "near-term cushion."
01/23/18
COWN
01/23/18
NO CHANGE
Target $250
COWN
Outperform
WellCare price target raised to $250 from $200 at Cowen
Cowen analyst Christine Arnold said WellCare could be a significant beneficiary from the tax reform bill given it is a growth health plan focused exclusively on government business. She believes Medicaid and Medicare Advantage are likely the biggest near-term winners and that tax reform will provide several opportunities to accelerate its growth trajectory. Arnold reiterated her Outperform rating on WellCare shares and raised her target on the stock to $250.

TODAY'S FREE FLY STORIES

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

13:14
07/21/18
07/21
13:14
07/21/18
13:14
Hot Stocks
Fiat names Jeep head as CEO as Marchionne's health worsens »

In a statement, Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$139.98

-2.65 (-1.86%)

, PM

Philip Morris

$84.31

3.41 (4.22%)

13:10
07/21/18
07/21
13:10
07/21/18
13:10
Hot Stocks
Ferrari to name former Philip Morris chairman as CEO »

The Board of Directors of…

RACE

Ferrari

$139.98

-2.65 (-1.86%)

PM

Philip Morris

$84.31

3.41 (4.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, TM

Toyota

$131.87

0.11 (0.08%)

12:51
07/21/18
07/21
12:51
07/21/18
12:51
Periodicals
Amazon, others working to counter Trump's tariff plans, Reuters says »

Big companies in the…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

TM

Toyota

$131.87

0.11 (0.08%)

AA

Alcoa

$40.32

-1.36 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

12:47
07/21/18
07/21
12:47
07/21/18
12:47
Periodicals
Fiat Chrysler's Sergio Marchionne to step down, NYTimes reports »

Fiat Chrysler's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

12:43
07/21/18
07/21
12:43
07/21/18
12:43
Periodicals
Fiat Chrysler to name Jeep's Manley as CEO, Reuters reports »

Fiat Chrysler has named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$187.21

-0.14 (-0.07%)

, TCEHY

Tencent

$0.00

(0.00%)

12:40
07/21/18
07/21
12:40
07/21/18
12:40
Periodicals
Alibaba, Tencent in talks to buy stake in WPP's Chinese unit, Reuters says »

Alibaba (BABA) and…

BABA

Alibaba

$187.21

-0.14 (-0.07%)

TCEHY

Tencent

$0.00

(0.00%)

WPP

WPP

$76.08

1.52 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, NFLX

Netflix

$361.33

-2.81 (-0.77%)

11:24
07/21/18
07/21
11:24
07/21/18
11:24
Periodicals
Amazon, Netflix to face tighter capital markets, Barron's says »

Since the Great…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

NFLX

Netflix

$361.33

-2.81 (-0.77%)

TSLA

Tesla

$313.49

-6.85 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 07

    Aug

  • 16

    Aug

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

, BLK

BlackRock

$503.01

-1.42 (-0.28%)

11:17
07/21/18
07/21
11:17
07/21/18
11:17
Periodicals
BlackRock, T. Rowe Price look like bargains, Barron's says »

With shares of many…

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

BLK

BlackRock

$503.01

-1.42 (-0.28%)

BEN

Franklin Resources

$31.99

-0.28 (-0.87%)

IVZ

Invesco

$25.46

-0.245 (-0.95%)

LM

Legg Mason

$33.37

-0.13 (-0.39%)

TROW

T. Rowe Price

$119.87

-0.85 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

ALV

Autoliv

$104.08

-0.57 (-0.54%)

, VNE

Veoneer

$50.81

-1.81 (-3.44%)

11:12
07/21/18
07/21
11:12
07/21/18
11:12
Periodicals
Automotive spinoffs offer exposure to autonomous, electric future, Barron's says »

Last month, Autoliv (ALV)…

ALV

Autoliv

$104.08

-0.57 (-0.54%)

VNE

Veoneer

$50.81

-1.81 (-3.44%)

DLPH

Delphi Technologies

$44.78

-0.355 (-0.79%)

APTV

Aptiv

$92.95

-2.02 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

07:58
07/21/18
07/21
07:58
07/21/18
07:58
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

F

Ford

$10.56

-0.115 (-1.08%)

GM

General Motors

$39.39

0.08 (0.20%)

HMC

Honda

$29.18

-0.19 (-0.65%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$131.87

0.11 (0.08%)

VLKAY

Volkswagen

$0.00

(0.00%)

GOOG

Alphabet

$1,184.77

-2.37 (-0.20%)

GOOGL

Alphabet Class A

$1,198.05

-1.21 (-0.10%)

PFE

Pfizer

$37.33

-0.03 (-0.08%)

NVS

Novartis

$82.28

1.47 (1.82%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$42.38

0.44 (1.05%)

BA

Boeing

$354.92

-0.57 (-0.16%)

MRK

Merck

$62.51

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Jul

  • 08

    Aug

  • 15

    Aug

  • 22

    Aug

  • 10

    Sep

  • 10

    Sep

  • 18

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Oct

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

ACN

Accenture

$166.47

-0.47 (-0.28%)

, EADSY

Airbus

$0.00

(0.00%)

04:55
07/21/18
07/21
04:55
07/21/18
04:55
Conference/Events
Farnborough International to hold an airshow »

Farnborough International…

ACN

Accenture

$166.47

-0.47 (-0.28%)

EADSY

Airbus

$0.00

(0.00%)

ATI

Allegheny Technologies

$26.65

0.08 (0.30%)

BAESY

BAE Systems

$0.00

(0.00%)

BDRBF

Bombardier

$0.00

(0.00%)

CAE

CAE

$20.96

0.17 (0.82%)

CW

Curtiss-Wright

$125.79

-0.12 (-0.10%)

DASTY

Dassault Systemes

$0.00

(0.00%)

ESLT

Elbit Systems

$118.98

0.64 (0.54%)

LMT

Lockheed Martin

$322.76

3.09 (0.97%)

BA

Boeing

$354.92

-0.57 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 16

    Aug

FNWB

First Northwest Bancorp

$16.11

0.36 (2.29%)

17:48
07/20/18
07/20
17:48
07/20/18
17:48
Hot Stocks
First Northwest Bancorp names Terry Anderson chief credit officer »

First Northwest Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.75

-0.05 (-0.32%)

17:42
07/20/18
07/20
17:42
07/20/18
17:42
Hot Stocks
Freeport McMoRan CAO Michael Arnold to retire »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$74.87

-0.24 (-0.32%)

, XLU

Utilities SPDR

$52.28

-0.39 (-0.74%)

17:39
07/20/18
07/20
17:39
07/20/18
17:39
General news
Week ending ETF Scorecard: Financials lead, Energy slumps »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$74.87

-0.24 (-0.32%)

XLU

Utilities SPDR

$52.28

-0.39 (-0.74%)

IYR

DJ US Real Estate Index Fund

$80.23

-0.68 (-0.84%)

XLP

Consumer Staples Sector SPDR

$52.84

0.3 (0.57%)

XLY

Consumer Discretionary Sector SPDR

$112.15

-0.47 (-0.42%)

XLB

S&P Select Materials SPDR

$58.31

-0.21 (-0.36%)

XLF

Financial Select Sector

$27.57

0.065 (0.24%)

XLV

Health Care Select Sector SPDR

$86.74

-0.17 (-0.20%)

XLK

Technology Select Sector SPDR

$72.55

0.01 (0.01%)

XLI

Industrial Select Sector SPDR

$74.44

-0.09 (-0.12%)

GLD

SPDR Gold Trust

$116.56

0.74 (0.64%)

SLV

iShares Silver Trust

$14.59

0.18 (1.25%)

USO

United States Oil Fund

$14.15

0.025 (0.18%)

UNG

United States Natural Gas Fund

$22.38

-0.06 (-0.27%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.62

0.03 (0.04%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.27

-0.335 (-0.29%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.78

-1.46 (-1.19%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.21

-0.35 (-0.34%)

SHY

iShares 1-3 Year Treasury Bond

$83.26

-0.005 (-0.01%)

IWD

iShares Russell 1000 Value

$123.07

-0.2897 (-0.23%)

IWF

iShares Russell 1000 Growth

$149.41

-0.04 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$25.10

-0.095 (-0.38%)

, FUJIY

Fujifilm

$0.00

(0.00%)

17:25
07/20/18
07/20
17:25
07/20/18
17:25
Hot Stocks
Xerox, Centerview settle matters related to proposed Fuji tie-up »

On July 20, 2018, Xerox…

XRX

Xerox

$25.10

-0.095 (-0.38%)

FUJIY

Fujifilm

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

STON

StoneMor Partners

$3.61

-0.015 (-0.41%)

17:15
07/20/18
07/20
17:15
07/20/18
17:15
Hot Stocks
Breaking Hot Stocks news story on StoneMor Partners »

Oaktree Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEF

Telefonica

$8.70

0.07 (0.81%)

17:11
07/20/18
07/20
17:11
07/20/18
17:11
Downgrade
Telefonica rating change at Goldman Sachs »

Telefonica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

, USO

United States Oil Fund

$14.15

0.025 (0.18%)

17:04
07/20/18
07/20
17:04
07/20/18
17:04
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 5.5K…

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

USO

United States Oil Fund

$14.15

0.025 (0.18%)

GLD

SPDR Gold Trust

$116.56

0.74 (0.64%)

FXE

Euro Currency Trust

$112.46

0.83 (0.74%)

FXC

CurrencyShares Canadian Dollar Trust

$75.17

0.81 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.15

(0.00%)

17:02
07/20/18
07/20
17:02
07/20/18
17:02
Syndicate
Breaking Syndicate news story on Citizens Community Bancorp »

Citizens Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKD

Parker Drilling

$0.30

-0.0044 (-1.46%)

17:01
07/20/18
07/20
17:01
07/20/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Parker Drilling »

Whitebox Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

RSLS

ReShape Lifesciences

$1.47

-0.02 (-1.34%)

17:00
07/20/18
07/20
17:00
07/20/18
17:00
Hot Stocks
Breaking Hot Stocks news story on ReShape Lifesciences  »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOX

Box

$26.13

-0.26 (-0.99%)

16:57
07/20/18
07/20
16:57
07/20/18
16:57
Initiation
Box initiated at First Analysis »

Box initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDX

Aldeyra

$7.95

-0.15 (-1.85%)

16:53
07/20/18
07/20
16:53
07/20/18
16:53
Syndicate
Breaking Syndicate news story on Aldeyra »

Aldeyra files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLRE

Greenlight Capital Re

$14.00

-0.15 (-1.06%)

16:46
07/20/18
07/20
16:46
07/20/18
16:46
Hot Stocks
Greenlight Capital Re announces departure of COO »

Greenlight Capital Ry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVI

Retail Value

$34.56

0.2 (0.58%)

16:38
07/20/18
07/20
16:38
07/20/18
16:38
Hot Stocks
Breaking Hot Stocks news story on Retail Value »

Luxor Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.